Viewing Study NCT05627856


Ignite Creation Date: 2025-12-24 @ 11:24 PM
Ignite Modification Date: 2026-01-05 @ 5:30 PM
Study NCT ID: NCT05627856
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-09-26
First Post: 2022-11-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of GNC-038 Injection in Patients With Relapsed or Refractory NK/ T-cell Lymphoma, AITL, and Other NHL
Sponsor: Sichuan Baili Pharmaceutical Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module